Upload

Loading...

Be Healthy: the first company-wide health and well-being initiative at Novartis

5,016

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 8, 2012

This video was produced for a segment in CNBC's "Responsible Business Television" series.

As a healthcare company, Novartis recognizes that employees are an integral part of the company's success and a healthy workforce underpins business growth. The "Be Healthy" initiative, first introduced in 2011, has expanded this year to include more than 95% of Novartis associates across 140 countries. This first company-wide health and well-being program provides a platform for managing health, promoting lifestyle changes and encouraging associates to increase physical exercise and make healthy eating choices. Be Healthy is an internal initiative for the benefit of Novartis associates.

Learn more on: http://www.novartis.com/corporate-res...

© 2012 Novartis AG

Loading...

Uploads from Novartis

  1. 169

    Novartis International Biotechnology Leadership Camp 2012

  2. 170

    Journey of Chronic Myeloid Leukemia (CML)

  3. 171

    A look at the past decade in GIST: Chapter 6

  4. 172

    A look at the past decade in GIST: Chapter 5

  5. 173

    A look at the past decade in GIST: Chapter 4

  6. 174

    Vision loss due to Retinal Vein Occlusion (RVO)

  7. 175

    Vision loss due to Diabetic Macular Edema (DME)

  8. 176

    Vision loss due to wet age-related macular degeneration (wet AMD)

  9. 177

    A look at the past decade in GIST: Chapter 3

  10. 178

    Building the next generation of scientists

  11. 179

    A look at the past decade in GIST: Chapter 2

  12. 180

    A look at the past decade in GIST: Chapter 1

  13. 181

    The impact of systemic juvenile idiopathic arthritis (SJIA)

  14. 182

    A difficult diagnosis: Understanding systemic juvenile idiopathic arthritis (SJIA)

  15. 183

    Advanced breast cancer 101

  16. 184

    The mTOR pathway in ER+ advanced breast cancer

  17. 185

    Life in a Circle

  18. 186

    Understanding advanced breast cancer

  19. 187

    A Gift for Living

  20. 188

    The Villages Miles Away

  21. Be Healthy: the first company-wide health and well-being initiative at Novartis

  22. 190

    Innovating to help eliminate malaria

  23. 191

    Malaria milestone video message

  24. 192

    Leo and Kya, friends against malaria

  25. 193

    The need for progress: what if?

  26. 194

    The myelofibrosis educational journey

  27. 195

    Understanding the progression of myelofibrosis

  28. 196

    Understanding the management of myelofibrosis

  29. 197

    The myelofibrosis disease burden

  30. 198

    The disease pathway associated with myelofibrosis

  31. 199

    New research developments in myelofibrosis

  32. 200

    Delivery of child-friendly antimalarial hits the 100 million mark

  33. 201

    Treating India's Leprosy patients

  34. 202

    Treating leprosy, caring for patients

  35. 203

    "SMS for Life" is expanding

  36. 204

    Becoming Christopher a fictional video trailer about living with Cystic Fibrosis

  37. 205

    Critical issues facing the advanced breast cancer patient community

  38. 206

    Advice to newly diagnosed advanced breast cancer patients

  39. 207

    Insight into the advanced breast cancer patient journey

  40. 208

    Pioneering an innovative social business model to fight malaria

  41. 209

    New media: drivers of democratization and development?

  42. 210

    What is it like living with myelofibrosis (MF)?

  43. 211

    What is the prognosis of myelofibrosis (MF)?

  44. 212

    How are myeloproliferative neoplasms (MPNs) diagnosed?

  45. 213

    What do we know about the development of myeloproliferative neoplasms (MPNs)?

  46. 214

    What is myelofibrosis (MF)?

  47. 215

    How is the patient journey for advanced breast cancer patients different?

  48. 216

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  49. 217

    What is progression free survival and why is it important?

  50. 218

    What guidance do you give patients and family coping with advanced breast cancer?

  51. 219

    What insights can you share with newly diagnosed patients?

  52. 220

    Molecular pathways:The future of research at NIBR

  53. 221

    The importance of organ donation

  54. 222

    Novartis BioCamp 2011 (German)

  55. 223

    Novartis BioCamp 2011 (French)

  56. 224

    How is research in advanced breast cancer evolving?

  57. 225

    What is hormone receptor positive (ER+/HER2-) advanced breast cancer?

  58. 226

    What can a patient expect if diagnosed with advanced breast cancer?

  59. 227

    What is progression free survival (PFS) as it relates to metastatic breast cancer therapy?

  60. 228

    What is the evolution of treatments and the progress that has been made in metastatic breast cancer?

  61. 229

    How does the advanced breast cancer treatment journey differ for patients?

  62. 230

    Novartis Be Healthy

  63. 231

    Novartis BioCamp 2011

  64. 232

    A sign from above

  65. 233

    Charlie

  66. 234

    Happy endings

  67. 235

    Herpes #1

  68. 236

    Herpes it's black and white

  69. 237

    Herpes the Ninja virus

  70. 238

    Magical elves with HSV

  71. 239

    Open happiness

  72. 240

    Play it smart

  73. 241

    Quarantine

  74. 242

    Strings

  75. 243

    Ah! Real herpes

  76. 244

    Down there

  77. 245

    Don't let herpes put you off

  78. 246

    Arogya Parivar: A social business model to improve health in rural India

  79. 247

    Living with multiple myeloma

  80. 248

    What are the symptoms of myelofibrosis (MF)?

  81. 249

    Gastrointestinal Stromal Tumors (GIST): A rare, life-threatening cancer

  82. 250

    Animals & Research: Think how far we've come

  83. 251

    SMS for Life

  84. 252

    Alcon: helping the world see better

  85. 253

    Cataract Surgery

  86. 254

    Life with cataracts

  87. 255

    CEO Joseph Jimenez on Alcon merger

  88. 256

    Improving access to healthcare: too big to solve alone

  89. 257

    Drug discovery and development process

  90. 258

    How bacterial meningitis affects the body

  91. 259

    10 years of Millennium Development Goals

  92. 260

    Introduction to bacterial meningitis

  93. 261

    Creating new drug pathways: Innovation in action

  94. 262

    Working in drug discovery: Innovation in action

  95. 263

    Researching Alzheimer's disease & dementia: Innovation in action

  96. 264

    Making the Right Choice: What a flu shot means to you

  97. 265

    Working & Volunteering: Robin G.

  98. 266

    CIBA VISION Celebrating World Sight Day

  99. 267

    Leprosy: treating disease and caring for patients

to add this to Watch Later

Add to